Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on nitration. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 2-fluoroadenine synthesis patent CN105130989A offers high yield and safety. Enables cost reduction in pharma manufacturing and reliable supply chain for antiviral drugs.
Patent CN103288757A reveals a novel solid-acid catalyzed nitration route for key TKI intermediates, offering significant cost reduction and simplified supply chains for pharmaceutical manufacturers.
Novel patent CN118184591A offers cost-effective synthesis for TYK2 inhibitor intermediates with high purity and scalable processes for global supply chains.
Patent CN113666862A details a novel nickel-catalyzed asymmetric nitration for chiral 3-nitroindoles, offering superior stereoselectivity and cost efficiency for pharmaceutical intermediates.
Patent CN113666862A reveals a nickel-catalyzed asymmetric nitration method for chiral 3-nitroindoles, offering high enantioselectivity and cost-effective manufacturing solutions.
Novel Fe(NO3)3 catalyzed method for gem-dinitro compounds. Safe, mild conditions for pharmaceutical intermediates. Cost-effective manufacturing solution.
Novel room temperature nitration process enhances purity and yield. Delivers substantial cost reduction and supply chain reliability for global pharmaceutical intermediates manufacturing.
Patent CN106748797B reveals a room temperature nitration method improving yield and purity for pharmaceutical intermediates supply chain stability.
Patent CN105418710B reveals a cost-effective route for 2,6-Dichloropurine Nucleoside. Enhance supply chain reliability with scalable pharmaceutical intermediates.
Patent CN105198710B details a high-purity synthesis route for 3-tert-butylphenol offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102516162A reveals a green copper-catalyzed nitration method. Offers high purity, cost reduction in API manufacturing, and reliable supply chain solutions.
Novel patent CN113979928B offers high-yield route for 2-chloro-5-nitropyridine. Reduces safety risks and improves supply chain stability for pharmaceutical intermediates.
Patent CN108727244A enables additive-free 2-pyrrolidone synthesis. Offers high purity, cost reduction, and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN112125805A reveals a novel selective nitration process for magnolol derivatives, eliminating column chromatography and enabling scalable, cost-effective production of high-purity intermediates.
Novel nickel-catalyzed asymmetric nitration for chiral 3-nitroindoles. High ee, mild conditions. Reliable pharmaceutical intermediates supplier for cost-effective scaling.
Patent CN103319414A details a simplified Telmisartan synthesis eliminating intermediate purification. Discover cost-effective manufacturing and high-purity supply solutions.
Patent CN120737008B details a novel chiral resolution method eliminating chromatographic columns. Mild nitration ensures high purity. Scalable synthesis reduces manufacturing costs for global supply chains.
Patent CN107098844B introduces a one-step nitration process using ferric nitrate nonahydrate enabling cost-effective manufacturing of high-purity C-5 nitro acyl indolines with enhanced supply chain resilience.
Novel nitrate hydrate-based method enables efficient geminal dinitro compound synthesis with improved safety profile and cost-effective manufacturing for pharmaceutical applications.
Innovative nickel-catalyzed asymmetric nitration process enables high-purity chiral intermediates with improved supply chain reliability and reduced manufacturing costs.